XCRP (Xcorporeal) Research & Development: $4.43 Mil (TTM As of Sep. 2009)


What is Xcorporeal Research & Development?

Xcorporeal XCRP -99.00% Research & Development is $4.43 Mil as of Sep. 2009.

Research & Development is the aggregate amount of research and development expenses during the year. Xcorporeal's Research & Development for the three months ended in Sep. 2009 was $0.59 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2009 was $4.43 Mil.

Xcorporeal  (OTCPK:XCRP) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Xcorporeal Research & Development Related Terms

Xcorporeal Research & Development Historical Data

* Premium members only.

The historical data trend for Xcorporeal's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xcorporeal Research & Development Chart

Xcorporeal Annual Data
Trend Feb99 Feb00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 1.29 7.14 20.92

Xcorporeal Quarterly Data
Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.69 2.02 1.22 0.61 0.59

Xcorporeal Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2009 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.43 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $4.43 Mil mean?
Xcorporeal (XCRP) has a Research & Development of $4.43 Mil as of Sep. 2009. Research and development expense is the total cost for research and development activities. View historical data on Xcorporeal and its competitors.
Is Xcorporeal's Research & Development too high?
Xcorporeal's current Research & Development is $4.43 Mil.
How does Xcorporeal's Research & Development compare to MFST and GTHP?
Xcorporeal's Research & Development of $4.43 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Xcorporeal and its competitors. Xcorporeal's current Research & Development is $4.43 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xcorporeal stock overvalued right now?
Xcorporeal (XCRP) has a current Research & Development of $4.43 Mil. The current Research & Development is $4.43 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Xcorporeal (XCRP), the current Research & Development is $4.43 Mil as of Sep. 2009. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Xcorporeal Business Description

Address 80 Empire Drive, Lake Forest, CA, USA, 92630
Xcorporeal Inc is a medical device company, developing an innovative extra-corporeal platform technology to be used in devices to replace the function of various human organs.